Jie Meng
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
- Catalysis top 5%
- Catalysis and Oxidation Reactions
Papers in
-
- RNA Interference and Gene Delivery 14
-
- Nanoparticles: synthesis and applications 17
- Catalytic Processes in Materials Science 16
- Co-authors
- Haiyan Xu (63 shared papers)Hua Kong (17 shared papers)Chen Wang (11 shared papers)Guofeng Guan (17 shared papers)Nengjie Feng (15 shared papers)Lijian Tao (31 shared papers)Ning Gu (7 shared papers)Hui Wan (15 shared papers)
- Journals
- Scientific Reports (7 papers)RSC Advances (6 papers)PLoS ONE (6 papers)International Journal of Nanomedicine (6 papers)Catalysis Science & Technology (5 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Jie Meng
207 papers receiving 6.0k citations
Jie Meng's Hit Papers
Peers
Comparison fields: 5 of 177
- Biomaterials 1.0k
- Catalysis 385
- Process Chemistry and Technology 104
- Biomedical Engineering 1.6k
- Materials Chemistry 1.6k
Countries citing papers authored by Jie Meng
This map shows the geographic impact of Jie Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Meng more than expected).
Fields of papers citing papers by Jie Meng
This network shows the impact of papers produced by Jie Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Meng. The network helps show where Jie Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Jie Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 210 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intubation and Ventilation amid the COVID-19 Outbreak Hit paper breakdown → | 2020 | 365 |
| 2 | Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial–mesenchymal transition and inflammation Hit paper breakdown → | 2020 | 280 |
| 3 | 2013 | 207 | |
| 4 | 2016 | 197 | |
| 5 | 2013 | 184 | |
| 6 | 2018 | 148 | |
| 7 | 2021 | 124 | |
| 8 | 2017 | 118 | |
| 9 | 2010 | 113 | |
| 10 | 2008 | 112 | |
| 11 | 2016 | 99 | |
| 12 | 2021 | 89 | |
| 13 | 2019 | 74 | |
| 14 | 2011 | 73 | |
| 15 | 2012 | 72 | |
| 16 | 2016 | 70 | |
| 17 | 2015 | 68 | |
| 18 | 2008 | 67 | |
| 19 | 2006 | 66 | |
| 20 | 2019 | 65 |
About Jie Meng
Jie Meng is a scholar working on Molecular Biology, Materials Chemistry, Biomedical Engineering, Biomaterials and Pulmonary and Respiratory Medicine, having authored 210 papers that have together received 6.1k indexed citations. Recurring topics across this work include Electrospun Nanofibers in Biomedical Applications (18 papers), Nanoparticles: synthesis and applications (17 papers), Graphene and Nanomaterials Applications (17 papers), Catalytic Processes in Materials Science (16 papers), Catalysis and Oxidation Reactions (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), RNA Interference and Gene Delivery (14 papers) and Immunotherapy and Immune Responses (10 papers). The work is most often cited by research in Biomaterials (1.0k citations), Catalysis (385 citations), Process Chemistry and Technology (104 citations), Biomedical Engineering (1.6k citations) and Materials Chemistry (1.6k citations). Jie Meng has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Haiyan Xu, Hua Kong, Chen Wang, Guofeng Guan, Nengjie Feng, Lijian Tao, Ning Gu, Hui Wan, Sishen Xie and Jian Liu. Their work appears in journals such as Scientific Reports, RSC Advances, PLoS ONE, International Journal of Nanomedicine and Catalysis Science & Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.